App-Quantinova.ai

ANTIPHOSPHOLIPID SYNDROME AND EPILEPSY: WHERE DO WE STAND?

M.A. Noureldine - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

CENTRAL NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS

T. Ben Salem - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

OCCURRENCE OF VASCULAR ACCESS THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON HEMODIALYSIS

N.O. El-Azizi - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

THE OXIDATIVE STRESS MARKERS AS RISK FACTOR FOR ENDOTHELIAL DYSFUNCTION IN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME

L. Stojanovich - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Nitroglycerin

DECREASED INTERLEUKIN-35 IS ASSOCIATED WITH HIGHER RISK OF PREGNANCY MORBIDITY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

N. Liu - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Interleukin

TISSUE BETA 2 GLYCOPROTEIN I IN BRAIN ISCHEMIC INJURY

C. Artusi - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ANTICOAGULATION AND LONG-TERM OUTCOMES IN PATIENTS WITH RENAL ARTERY STENOSIS AND ANTIPHOSPHOLIPID SYNDROME

A. Casian - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Hydroxychloroquine

LONG TERM USE OF HYDROXYCHLOROQUINE IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY

E. Nuri - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

RISK FACTORS FOR ADVERSE PREGNANCY OUTCOME IN FIRST-LINE TREATED PREGNANCIES IN ANTIPHOSPHOLIPID ANTIBODIES-POSITIVE WOMEN ACCORDING TO DIFFERENT TREATMENT STRATEGIES: RESULTS FROM OUR 30 YEAR-EXPERIENCE PREGNANCY CLINIC

M.G. Lazzaroni - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

LOW-DOSE ASPIRIN AS PRIMARY PROPHYLAXIS FOR CARDIOVASCULAR EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A LONG-TERM FOLLOW UP

S. Fasano - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Albyl-E

THE INFLUENCE OF MAGNETIC PROPERTIES OF THE ADSORBENTS ON EFFICIENCY OF EXTRACORPOREAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID SYNDROME

I.P. Gontar - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Intratect

RELIABILITY AND SAFETY OF A NOVEL AUTOINJECTOR FOR SELF-ADMINISTRATION OF SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

S.Z. Sheikh - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Belimumab

SELECTIVE FACTOR XA INHIBITORS IN TREATMENT AND PREVENTION OF THROMBOSES IN PATIENTS WITH RHEUMATIC DISEASES

N. Seredavkina - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Fondaparinux sodium

HYPOCOMPLEMENTEMIA ASSOCIATES WITH THROMBOSIS IN SLE PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

L. Durcan - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Eculizumab

INDUCTION OF NETOSIS-MEDIATED CELL DEATH IN ANKYLOSING SPONDYLITIS PATIENTS

A. Escudero-Contreras - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Superoxide dismutase

HEMOSTATIC MECHANISMS MAY PLAY A ROLE IN THE DEVELOPMENT OF THROMBOSIS IN MALE PATIENTS WITH BEHCE-S DISEASE: A THROMBOELASTOGRAPHIC ANALYSIS

B. Kara Kivanc - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

ASYMPTOMATIC DEEP VEIN THROMBOSIS IN ANCA-ASSOCIATED VASCULITIDES

E. Makarov - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Prednisolone

POST-THROMBOTIC SYNDROME AND VENOUS DISEASE SPESIFIC QUALITY OF LIFE IN PATIENTS WITH VASCULAR BEHCE-S DISEASE

F. Alibaz-Oner - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

BEHCE-S DISEASE IN WOMEN: A TUNISIAN SERIES OF 135 PATIENTS

T. Ben Salem - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

CLINICAL FEATURES OF ARDIOVASCULAR INVOLVEMENT IN BEHCE-S DISEASE

N. Gao - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

Filters

7277 Abstracts